68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

Peter Donato; Andrew Morton; John Yaxley; Sachinka Ranasinghe; Patrick Teloken; Samuel Kyle; Geoff Coughlin; Rachel Esler; Nigel Dunglison; Robert A. Gardiner

doi:https://doi.org/10.1007/s00259-019-04620-0

doi.org/10.1007/s00259-019-04620-0

68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?

,

,

..., Robert A. Gardiner

43

European Journal of Nuclear Medicine and Molecular Imaging9.10

Volume: 47, Issue: 8, Pages: 1843 - 1851

Published: Jan 7, 2020

Abstract

68Ga prostate specific membrane antigen PET/CT (68Ga-PSMA PET/CT) may be superior to multiparametric MRI (mpMRI) for localisation of prostate cancer tumour foci, however the concordance and differences between 68Ga-PSMA PET/CT and mpMRI when applied to all biopsied patients and potential benefit in patients with negative mpMRI is unclear. Retrospective analysis of patients undergoing mpMRI, prostate biopsy and 68Ga-PSMA PET/CT over a 3-year...